-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Opus Genetics with Overweight Rating, Announces Price Target of $15

Benzinga·03/30/2026 11:19:33
Listen to the news
Cantor Fitzgerald analyst Steve Seedhouse initiates coverage on Opus Genetics (NASDAQ:IRD) with a Overweight rating and announces Price Target of $15.